APRICUS BIOSCIENCES INC.
President and CEO: Bassam Damaj.
Revenue: $4.97 million in 2010; $2.97 million in 2009.
Net loss: $29.51 million in 2010; $32.04 million in 2009.
No. of local employees: 20.
Headquarters: San Diego’s Sorrento Valley area.
Year founded: 1987.
Stock symbol and exchange: APRI on Nasdaq.
Company description: A pharmaceutical research and development company with multiple products centered on its patented drug delivery system, NexACT. Therapeutic areas include oncology, sexual dysfunction, autoimmune diseases, and inflammation.
August has been a huge month for San Diego-based Apricus Biosciences Inc...